New York · Nonprofit
CARCINOID CANCER FOUNDATION
CARCINOID CANCER FOUNDATION (New York) receives grants from 23 organizations whose IRS filings report $332,881 to it, the largest being DONOR ADVISED CHARITABLE GIVING INC ($81,150). 9 of them have funded it in more than one year, and 72% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2026
- $20k
- Funders on record
- 23
- Grants received
- $333k
- Net assets
- $0
What Carcinoid Cancer Foundation does
Mission
Organization mission: to provide education and awareness information to patients and families of patients impacted by carcinoid and neuroendocrine tumors, as well as to serve as advocates throughout the community connecting physicians, caregivers, patients, families of patients and those organizations serving the community with diagnostic tools and methods as well as those providing treatment.
As stated on its FY2026 Form 990.
Program
On its FY2025 return the organization reported a significant change in how it conducts a program.
Effective 2/28/26, the board of directors voted to cease operations and dissolve the entity. Since 1968, the organization proudly served the community providing valuable information and awareness about carcinoid and neuroendocrine tumors. The remaining assets of the organization will be donated to neuroendocrine cancer foundation, a not-for-profit, who will continue to fullfull the organization's historical mission.
Its own explanation, from Schedule O of that return (Part III, line 3).
Provides information and education for medical professionals, patients, caregivers, and the general public; provides e-mail and telephone support; works to improve access to accurate and up-to-date information. Digital outreach nationally and internationally through ccf's website,e-newsletter, blog and social media channels, including facebook, youtube and twitter, reaches over 400,000 people annually in more than 150 countries. Encourages and supports research in the area of carcinoid and neuroendocrine tumors.
$358,215 spent100% of program spending
The program described on its FY2025 Form 990. Program spending in total: $358,215.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2025 to 2026, from $597k to $0 (−100%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
100% of CARCINOID CANCER FOUNDATION’s revenue is contributions — more donation-reliant than the typical peer (100% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 6 of the last 10 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Keith Warner
CEO/chairman/treasurer
As listed on its FY2026 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 3 funders to 8 funders, grant income rose $45k → $46k.
7 of 23 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 72% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of CARCINOID CANCER FOUNDATION’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
CARCINOID CANCER FOUNDATION has a broad base — no single funder exceeds 24% of grant income, and it takes 3 funders to reach half.
the vertical line marks half of all grant income — 3 funders to its left
74% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund CARCINOID CANCER FOUNDATION.
Largest funder’s share by year: 2017 94% · 2018 63% · 2019 39% · 2020 71% · 2021 55% · 2022 30% · 2023 32% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
15% of CARCINOID CANCER FOUNDATION's funders are still giving 3 years after their first grant; 39% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
72% of CARCINOID CANCER FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $93k that is directly attributable, 99% of it comes from funders outside New York, across 10 states.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $240k arriving through sponsors registered in 6 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
CARCINOID CANCER FOUNDATION's revenue fell 97% between 2017 and 2026.
this organization peer median middle 50% of peers· 162 health nonprofits under $100k, FY2026
Organizations like CARCINOID CANCER FOUNDATION
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
59% of spending goes to programs.
Governance
Public support
100%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for CARCINOID CANCER FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds CARCINOID CANCER FOUNDATION?
- CARCINOID CANCER FOUNDATION (New York) receives grants from 23 organizations whose IRS filings report $332,881 to it, the largest being DONOR ADVISED CHARITABLE GIVING INC ($81,150). 9 of them have funded it in more than one year, and 72% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does CARCINOID CANCER FOUNDATION have?
- IRS filings report 23 organizations giving $332,881 in grants to CARCINOID CANCER FOUNDATION, 9 of which have funded it in more than one year.
- Who is the largest funder of CARCINOID CANCER FOUNDATION?
- DONOR ADVISED CHARITABLE GIVING INC is the largest funder on record, with $81,150 in grants. The full list of funders is on this page.
- How can an organization like CARCINOID CANCER FOUNDATION find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Carcinoid Cancer →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2026 (financials across 2017–2026), and the filings of 23 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing